Anticoagulation therapy : improving processes. Hilary Merrett and Fiona Gale, CHKS 18 th October 2010

Similar documents
Establishing Special and Common Cause Variation

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist

Venous Thromboembolism National Hospital Inpatient Quality Measures

Failure Mode and Effects Analysis (FMEA) Margaret Colquhoun

Avoiding harm in primary care

Failure Modes Effects Analysis of Morphine Prescribing

Ensuring Safety of Anticoagulation Therapy

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16

SPSP Networking Day VTE. Tuesday 30 May 2017 COSLA, Edinburgh

Drug Prescribing. Ravi Menon

Misunderstandings of Venous thromboembolism prophylaxis

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital

What You Should Know

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS

An Audit of the Post-Operative Management of Patients taking Warfarin

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

Iatrogenesis in the frail elderly

AUDIT REPORT. Salisbury District Hospital. Odstock Road. Salisbury. Wiltshire. February Page 1 of 20

TG100 Implementation Guide - FTA

High alert medicines

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton

Draft Falls Prevention Strategy

Reducing the risk of patient harm: A focus on opioids

NHS RightCare scenario: Getting the dementia pathway right

Serious Incident Investigations. Elaine Spencer Serious incident Investigator

Index. Note: Page numbers of article titles are in boldface type.

References: Murtagh J. Murtagh s General Practice. 5 th edn. Sydney: McGraw Hill; 2010.

This document outlines the clinical risks assessed as AFAP within INRstar.

High Alert Medications: Reducing Patient Harm. Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS

Medication Safety Tips. Gerry Maloney, DO, CPPS Dept of Emergency Medicine CWRU/MetroHealth Medical Center

Medication Safety Learning from Ontario Coroners Cases Focus on Opioids

support support support STAND BY ENCOURAGE AFFIRM STRENGTHEN PROMOTE JOIN IN SOLIDARITY Phase 3 ASSIST of the SASA! Community Mobilization Approach

Identifying and reducing medication errors in mental health

PROCEDURE REFERENCE NUMBER SABP/EXECUTIVE BOARD/0017/PROCEDURE15 PROCEDURE NAME MEDICINES PROCEDURE 15: METHOTREXATE

Information & statistics related to alcohol & drug misuse and community pharmacybased brief advice & intervention

Multidisciplinary Geriatric Trauma Care Guideline

Lesson 2: Observation

For many people, the warnings for a medication can read like the fine print of a home mortgage.

Medicines in Scotland: What s the right treatment for me? Information for patients and the public

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help

Cancer associated thrombosis palliative care and the end of life. Tracy Anderson May 2017

PHARMACY INTERVENTION RECORD FORM 1.7 Medicine

Root Cause Analysis The Tools. Angie Abbott Head of Podiatry and Orthotics Torbay and Southern Devon

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1

USEFUL RESPONSES TO ROUTINE ENQUIRY DOUBTERS

Failure Mode Effect Analysis of Patient Controlled Epidural Analgesia

Pharmacy Leadership, Touching all the Bases

apability, pportunity and otivation

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

Introduction. Peripheral arterial disease. Hospital inpatient data - 5,498 FCE (2009/10), & 530 deaths in England alone

UW MEDICINE PATIENT EDUCATION. Treating Blood Clots. What is a blood clot? DRAFT

THOUGHTS, ATTITUDES, HABITS AND BEHAVIORS

Tips and Tools to Drive Best Practice

Aim. Managing high risk medicines in primary care. Intended outcomes. Introduction. Risk associated with prescribing

Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin

Polypharmacy and Deprescribing. A special report on views from the PrescQIPP landscape review

The first stop for professional medicines advice. Community Pharmacy Oral Anticoagulant Safety Audit

NAS NATIONAL AUDIT OF SCHIZOPHRENIA. Second National Audit of Schizophrenia What you need to know

Medicine Errors. H.Beadle, L.Baxendale, Clinical Governance Pharmacists. Coventry and Warwickshire Partnership Trust Medicines Management Team

DVT - initial management NSCCG

Monitoring of patients prescribed lithium

Deep Vein Thrombosis

Six step guide to improving diabetes footcare. Putting feet. first

The research questions are presented in priority order, and are further elaborated with lay summaries and three-part questions where applicable.

CYM Campaign Toolkit. changeyourmindni.org

Pharmacy Prior Authorization

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins

Pathology Service User Guide Haematology

Recognizing Alzheimer's Disease at the Earliest Stages: Key Signs and Symptoms

FMEA and RCA: the mantras * ; of modern risk management. FMEA and RCA really do work to improve patient safety. COMMENTARY FMEA and RCA.

Deviations Inspection Observations & Issues to Consider for Achieving Compliance

Suspected Deep Vein Thrombosis (DVT) Assessment

9 Diabetes care. Back to contents

Venous Thromboembolism. Prevention

BASIC VOLUME. Elements of Drug Dependence Treatment

Root Cause Analysis & Environmental Assessments. Karin Hoelzer, DVM, Ph.D. November 9, 2017

Alcohol Opiates Other:

Prostate Biopsy Alerts

*Corresponding Author:

SAVAYSA (edoxaban tosylate) oral tablet

2.5 Other Hematology Consult:

Appendix B Patient Stories

Elements for a Public Summary Overview of disease epidemiology

VOLUNTARY ADMISSION BY BAYER HEALTHCARE

High Alert Medications in the long-term care setting. Carrie Allen PharmD, CGP, BCPS, CCHP

CLINICAL AUDIT. Safe and Effective. Anticoagulation. with Warfarin

New v1.0 Date: December 2015 Patricia Wain - Associate Director Physical Care. Kenny Laing - Deputy Director of Nursing

A new model for prescribing varenicline

Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July Gosport Hospital Report & RUH Assurance

Step 4: ISO9001:2015 -Risk Based Planning Cont. Methodology used to Prioritise and Control Risk

HA CONVENTION Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward

Patient Information. Preventing and treating blood clots

How to correctly complete the New Medical Certificate of Cause of Death (MCCD)

Hot Topics: Transitions of Care

Transcription:

Anticoagulation therapy : improving processes using risk management tools Hilary Merrett and Fiona Gale, CHKS 18 th October 2010

Risk management tools and anticoagulation therapy The applicable processes Focus on Failure Mode Effects Analysis Key risks and findings in Anticoagulation therapy Using analytical tools for improvement

High Risk Drugs

High Risk Drugs Drugs that pose the most risk to the organization in terms of harm Represent the drugs with low therapeutic index small changes in dose can have severe consequences

NPSA Patient Safety Observatory report 4 Medicines most frequently associated with severe harm were: Anticoagulants Antibiotics (allergy related) Injectable sedatives Chemotherapy Opiates Antipsychotics Insulin Infusion fluid

Using Analytical tools : prospective

Understanding why things go wrong Learning from experience Systems thinking Prospective and retrospective techniques Human reliability analysis : human factors Assessing reliability through an understanding of human behaviours in the context of their environments

Human Reliability Analysis Prospective approach Error probability understanding likelihood Takes process of care, rather than single case or incident Developed in industries where you need to know Developed in industries where you need to know in advance of operations eg nuclear.

Human Reliability Analysis Fault Tree Analysis Probabilistic Risk Assessment Event Tree Analysis Hazard Analysis sand Critical Control Points Failure Modes and Effects Analysis HAZOP

The FMEA process DEFINE THE ESTABLISH MAP THE HAZARD ISSUE THE TEAM PROCESS ANALYSIS ACTIONS AND OUTCOMES

FMEA process in a nutshell! Each step what could go wrong failure mode why could it go wrong what could happen. Identify possible causes for each failure mode Identify possible effects Scoring of risk of each failure: product of 3 measures occurrence / severity and detectability Risk Priority Number Identifying highest scoring failures to prioritise for action

Choosing the team Individuals closest to the event or issues involved Individuals critical to implementation of potential changes Leader with a broad knowledge base, who is respected and credible Someone with decision making authority Individuals with diverse knowledge bases Process experts to encourage development of functional processes

Examples in practice

Steps Failure Mode Failure causes Failure Effects Likelihood of Occurrence 1 Is Anticoagulation indicated? 1A 1B 1C Is diagnosis correct? Are there contraindications of disease interactions? Are there drug or food interactions? Can they be managed? Diagnosis tests not performed Doesn t meet standards of practice Clinicians unaware of standards No or incomplete patient information Not evaluated Diagnosis inconclusive Didn t know patient had a given contraindication (or epidural) Interpretation biases Incomplete medication history No computer alerts Skipped alert Incomplete alert Herbal / supplement interactions Interactions not considered Didn t check Anticoagulant administered when not indicated No treatment given when indicated Failure of test to diagnose Inappropriate prescribing of anticoagulants Bleeding Death Thrombosis Bleeding Death Thrombosis Severity can range from 1-10 Likelihood of Detection Severity Risk Priority Actions to reduce occurrence of failure 1 5 4 20 All caregivers double check diagnosis 1 1 8 8 2 9 8 144 Use 2 tests to diagnosis when possible. Repeat inconclusive tests 2 1 7 14 Pharmacists check indication Educate prescribers Establish treatment guidelines 2 2 10 40 Pharmacists double check Establish treatment guidelines that include information on contraindications. 7 2 1 14 Use pharmacy computer system that screens for drug interactions take a complete medication history including herbal/supplement information 7 2 10 140

Steps Failure Mode Failure causes Failure Effects Likeliho od of Occurre nce 2 Initiate therapy: Write order 2A Initiate policy, pre-printed orders or protocol if exists Don t exist Not followed Outdated, inaccurate Providers use differently Unclear when to use Pre-printed order wrong Haven t standardised 2B Select drug Not formulary Not available Wrong drug for this patient Drug specific contraindication exists 2C Select dose Wrong dose Wrong route Age, size, renal function not considered Mixed up drug or strength Order of magnitude error in writing dose 2D Write order Illegible Inappropriate abbreviations Order unclear Key elements of order omitted Left out sections of preprinted orders Transcription errors No read back on verbal Orders Wrong drug Wrong dose Likeliho od of Detecti on Severity Risk Priority Actions to reduce occurrence of failure 7 8 4 224 Establish guidelines. Use inpatient warfarin protocols Do not use sliding scale warfarin schemes Cause bleed 4 1 4 16 Use protocols Increase bleeding 1 3 9 27 Check for allergies risk Diagnose heparin induced thrombocytopenia appropriately Increase bleeding risk Dose too high: develop bleed Dose too low: develop thrombosis Wrong dose or drug administered. Bleeding 7 1 4 28 1 3 10 30 0 Pick one drug for formulary for LMWH Pharmacist picks dose 7 1 6 42 Avoid verbal orders. If do need to use, use read back procedure. Follow do not use abbreviations use pre-printed order forms.

Going through the process Steps in process Failure Mode Failure Causes Failure Effects Likelihood of Occurrence Likelihood of Detection Severity Risk Priority Number Actions to reduce occurrence

Lessons from other settings Must have backing and involvement of senior management Is there anyone who understands the whole process? Improvements often about simplification and Improvements often about simplification and standardisation

Why use FMEA? Proactively prevents harm Analyses system for vulnerabilities Identifies ways to help prevent harm IHI methodology and templates exist Has been shown to reduce variances and number of serious harm incidents Helpful in complex processes Substantial investment of time and resource high priority issues only therefore But...consider retrospective analysis

Retrospective analysis

A Root Cause Mentality An insatiable desire to understand why things go wrong, why people do what they do, and how things got into their present state. A realistic awareness of WHY things go wrong not just the physical reasons, but the human, latent, and root reasons also. A Reluctance to Blame A Desire to Understand Robert Nelms

RCA approach: deconstructing failure cause Key problems Acts or omissions in care which led to the events (= failure mode) Examples: Patient received wrong medication Conveying the wrong information Not following policy/protocol Working beyond competence

RCA approach: for each key problem - contributory factors Team and and Social Equipment and Resources Education and Training Task Organisation Individual Patient Communications Working Conditions

Case study Elderly gentleman admitted 22.10.08 - breathing difficulties COPD; epilepsy; type II diabetes ; renal and heart failure Previous DVT on warfarin long term Injectable heparin prescribed on admissions instead No note of change of anticoagulation regime in notes Warfarin not included on discharge summary sent to GP 25.10.08 8.12.08 patient had breathing difficulties. Ambulance called Could not be resuscitated PM showed cause of death1) pulmonary embolism 2) DVT limb

Factors contributing to failure / problem Problems/ Issues Contributory Factors (CDP / SDP)* Patient Task Individual Staff Team and Social Education and training Equipment / Resources Communicatio n Working Condition Organisational and strategic FAILURE TO REPRESCRIBE WARFARIN NO COMPUTER ALERT LACK OF KNOWLEDGE TOO MANY STAFF INVOLVED NOONE TAKING RESPONSIB ILIY LACK OF INADEQUATE STAFF CLINICAL TRAINING HANDOVER SHORTAGES GOVERNANCE STRUCTURES UNCLEAR

Improvement actions: strengthening controls Prospective and reactive barrier analysis Failsafe analysis what has failed in the past is it easy to follow guidelines? do the guidelines always apply are they out of hours proof? will the right people get the right training? will people be able to point up problems or potential problems?

Retrospective analysis or prospective? Experience is a comb which nature gives us when we are bald